Nuclear magnetic resonance spectroscopy of plasma to distinguish between malignant and benign diseases causing jaundice and cholestasis
- 1 October 1993
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 119 (10), 622-626
- https://doi.org/10.1007/bf01372726
Abstract
The sera of 51 patients with malignant (n=25) and benign (n=26) hepatopancreatobiliary disorders were analysed by1H magnetic resonance spectroscopy (NMR) in order to distinguish between malignant and benign diseases causing jaundice and/or cholestasis. Macromolecular linewidths were determined both manually and automatically with a computed analysis, and both methylene (CH2) and methyl (CH3) resonances were evaluated. The mean linewidth of the CH3 peak was significantly narrower in the patients with malignant disease than in the patients with benign disease both in the manual and computed analyses, but no significant differences in the CH2 peak were detected. Diagnostic sensitivity and specificity of the CH3 peak determined in the computed analysis were 92% and 27% respectively. In the light of the current study, it seems obvious that because overlap between benign and malignant groups was too great,1H NMR spectroscopy of plasma is not of practical value in distinguishing between benign and malignant causes of jaundice and/or cholestasis.Keywords
This publication has 15 references indexed in Scilit:
- A lineshape fitting model for 1H NMR spectra of human blood plasmaMagnetic Resonance in Medicine, 1991
- Detection of malignant tumours by multivariate analysis of proton magnetic resonance spectra of serumEuropean Journal of Cancer and Clinical Oncology, 1990
- Lack of Efficacy of Water-Suppressed Proton Nuclear Magnetic Resonance Spectroscopy of Plasma for the Detection of Malignant TumorsNew England Journal of Medicine, 1990
- Proton Nuclear Magnetic Resonance Spectroscopy of Plasma from Healthy Subjects and Patients with CancerNew England Journal of Medicine, 1990
- Effect of Triglyceride Levels on Methyl and Methylene Envelope Line Widths in Proton Nuclear Magnetic Resonance Spectroscopy of Human PlasmaNew England Journal of Medicine, 1989
- Monitoring of patients with nonseminomatous testicular cancer by nuclear magnetic resonance spectroscopy of plasmaEuropean Journal of Cancer and Clinical Oncology, 1989
- Detection of tumours with nuclear magnetic resonance spectroscopy of plasmaEuropean Journal of Cancer and Clinical Oncology, 1989
- 1H and 13C nuclear magnetic resonance studies of plasma from patients with primary intracranial neoplasmsJournal of Neurosurgery, 1988
- Detection of malignant tumors: Water‐suppressed proton nuclear magnetic resonance spectroscopy of plasmaMagnetic Resonance in Medicine, 1987
- Detection of Malignant TumorsNew England Journal of Medicine, 1986